Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuhui Ma

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Nature Communications|January 28, 2026
Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trialHouyu Ju, Yunteng Wu, Chaoji Shi, et al.
Nature Communications|January 13, 2021
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunityBotai Li, Lili Zhu, Chunlai Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2024
Deciphering the role of the MALT1-RC3H1 axis in regulating GPX4 protein stabilityJun Wang, Long Liao, Beiping Miao, et al.
Genome Medicine|October 19, 2021
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancerYuchen Guo, Jun Wang, Bente Benedict, et al.
Science Advances|April 1, 2026
Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanomaXuhui Ma, Yanni Ma, Li Zhang, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Cryobiology|July 13, 2025
Expert consensus on cryosurgery therapy of mucosal melanoma on head and neckYadong Wu, Guoxin Ren, Moyi Sun, et al.
Cancer Cell|November 8, 2024
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Haigang Geng, Xupeng Yang, et al.
Nature Medicine|March 2, 2023
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancerJoris van de Haar, Xuhui Ma, Salo N Ooft, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Nature Communications|January 28, 2026
Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trialHouyu Ju, Yunteng Wu, Chaoji Shi, et al.
Nature Communications|January 13, 2021
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunityBotai Li, Lili Zhu, Chunlai Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2024
Deciphering the role of the MALT1-RC3H1 axis in regulating GPX4 protein stabilityJun Wang, Long Liao, Beiping Miao, et al.
Genome Medicine|October 19, 2021
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancerYuchen Guo, Jun Wang, Bente Benedict, et al.
Science Advances|April 1, 2026
Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanomaXuhui Ma, Yanni Ma, Li Zhang, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Cryobiology|July 13, 2025
Expert consensus on cryosurgery therapy of mucosal melanoma on head and neckYadong Wu, Guoxin Ren, Moyi Sun, et al.
Cancer Cell|November 8, 2024
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Haigang Geng, Xupeng Yang, et al.
Nature Medicine|March 2, 2023
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancerJoris van de Haar, Xuhui Ma, Salo N Ooft, et al.
Pageof 7